Study of immune and tumor interactions in digestive cancers
Treatments studied
Part of Cancer, Digestive system clinical trials.
This study looks at how tumors in the digestive system interact with the body’s immune system and the surrounding environment. Results may help improve understanding of these cancers and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed digestive cancer: colorectal, pancreatic, bile duct, stomach/esophagus, or neuroendocrine digestive tumor
- Your diagnosis was made sometime between 1998 and 2030
- You are 18 years or older
- You can provide signed consent to join the study (except if the patient is deceased)
- You are covered by France’s social security health system (including CMU)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps doctors better understand your cancer by doing tumor/cancer profiling as part of research. If you qualify, your participation may help improve how cancers are studied and matched with future treatments.
This trial studies how the immune system responds to colon cancer, especially when it has spread. Researchers want to understand and possibly boost immune reactions during surgery. It may help find better ways to treat colorectal cancer in the future.
This trial monitors how your prescribed targeted cancer medicine moves through your body by doing extra blood tests. The goal is to understand the drug’s levels and dosing in people with advanced digestive cancers, so treatment can be better managed.
This study follows people with colorectal, pancreatic, or bile duct cancer to learn how the body’s immune system and cancer surroundings affect disease. The results may help guide better future treatments, even though this is more of an observational cohort study.
This study looks at what makes some cancers more “noticeable” to the immune system. It may help researchers design better future immunotherapy by collecting information (often including blood samples) from people with different cancers.
This study builds a clinical and biological database for people newly diagnosed with certain cancers. It may help doctors better understand cancer patterns and improve future care, and it involves agreeing to extra blood samples.
Hear when a new Gastrointestinal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.